Leping Li
Corporate Officer/Principal bei Presidio Pharmaceuticals, Inc.
Ursprung des Netzwerks ersten Grades von Leping Li
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
Presidio Pharmaceuticals, Inc.
 Presidio Pharmaceuticals, Inc. BiotechnologyHealth Technology Presidio Pharmaceuticals, Inc. discovers and develops small-molecule antiviral therapeutics. Its products in pipeline include NS5A, PPI-668 and PPI-383 for treating hepatitis C virus infections. The company was founded by Omar K. Haffar, Antoun Nabhan and David V. Jobes in March 2006 and is headquartered in San Francisco, CA.
7
| Holding Company | Biotechnology | 7 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Leping Li
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Director of Finance/CFO | |
| IDENIX PHARMACEUTICALS INC | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
TRIA Beauty, Inc.
 TRIA Beauty, Inc. Medical SpecialtiesHealth Technology TRIA Beauty, Inc. provides light based therapeutic beauty devices. It offers TRIA Laser Hair Removal System for laser removal of hair and TRIA Skin Perfecting Blue Light for mild to moderate inflammatory acne with a proprietary cleanser and serum for overall complexion improvement. The company was founded in 2003 by Tobin C. Island, Robert E. Grove, Jonathon T. Pearson and Mark V. Weckwerth and is headquartered in Dublin, CA. | Medical Specialties | Director/Board Member | |
| HYPERION THERAPEUTICS INC | Pharmaceuticals: Major | Director/Board Member | |
NextWave Pharmaceuticals, Inc.
 NextWave Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology NextWave Pharmaceuticals, Inc. operates as a pharmaceutical company which focuses on the development and commercialization of products for the treatment of attention deficit hyperactivity disorder. The company was founded by Mahendra G. Shah on September 25, 2006 and is headquartered in New York, NY. | Pharmaceuticals: Major | Director/Board Member | |
Nicox Ophthalmics, Inc.
 Nicox Ophthalmics, Inc. Pharmaceuticals: MajorHealth Technology Nicox Ophthalmics, Inc. develops ocular diseases treatment products. It offers extensive pipeline such as a number of clinical and pre-clinical programs that principally target ocular allergy, ocular inflammation, and blepharitis. The company was founded by Thomas Cavanagh on December 21, 2007 and is headquartered in Fort Worth, TX. | Pharmaceuticals: Major | Director/Board Member | |
| ACCELERATED PHARMA INC | Medical Specialties | Chairman | |
ROTH Capital Partners LLC
 ROTH Capital Partners LLC Investment Banks/BrokersFinance ROTH Capital Partners LLC is a broker/dealer headquartered in Newport Beach, California. The firm was founded in 2001 and is a subsidiary of CR Financial Holdings, Inc. They offer institutional sales and trading services. Their broad institutional coverage includes investors in North America, Canada, UK, Europe and other international territories. | Investment Banks/Brokers | Corporate Officer/Principal | |
| Yale University | College/University | Undergraduate Degree | |
| University of California San Diego | College/University | Undergraduate Degree | |
| University of Kansas | College/University | Undergraduate Degree | |
| The University of California, San Francisco | College/University | Corporate Officer/Principal | |
| Georgetown University | College/University | Doctorate Degree | |
Bay City Capital LLC
 Bay City Capital LLC Investment ManagersFinance Bay City Capital LLC (Bay City Capital) is a venture capital firm founded in 1997 by Fred Craves, John Diekman, and Thomas Pritzker. The firm is headquartered in California, United States. | Investment Managers | Private Equity Investor Corporate Officer/Principal | |
| Universidad de Buenos Aires | College/University | Doctorate Degree | |
| PHARCO PHARMACEUTICALS | Pharmaceuticals: Major | Director of Finance/CFO | |
| Universidad Mariano Egaña | College/University | Undergraduate Degree | |
Infectious Diseases Society of America
 Infectious Diseases Society of America Miscellaneous Commercial ServicesCommercial Services The Infectious Diseases Society of America is a non-profit company that provides clinical practice guidelines development and guideline panelists for infectious diseases. The company is based in Arlington, VA and has subsidiaries in the United States. The company specializes in antimicrobial stewardship and have established Antimicrobial Stewardship Centers of Excellence. The CEO of the company is Christopher Busky. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| The Genentech Foundation | Investment Trusts/Mutual Funds | Director of Finance/CFO | |
| Cytokine Networks | Corporate Officer/Principal | ||
| International Therapeutics, Inc. | College/University | Founder | |
Kamfarma SA
 Kamfarma SA Medical DistributorsDistribution Services Kamfarma SA engages in manufacturing, trading and sale of pharmaceutical products. The company was founded in 1978 and is headquartered in Lugano, Switzerland. | Medical Distributors | Chief Executive Officer | |
| ALLAKOS INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
| UCLA Anderson School of Management | College/University | Masters Business Admin | |
| Lifescience Economics | Corporate Officer/Principal | ||
Naia Rare Diseases LLC
 Naia Rare Diseases LLC Medical/Nursing ServicesHealth Services Naia Rare Diseases, Inc. develops pharmaceutical drugs for Short Bowel Syndrome (SBS) and other rare gastrointestinal diseases. The firm offers NB 1001 for adult SBS, NB 1001 for pediatric SBS, and NB 1002, a GLP-2 agonist. The company was founded by H. Daniel Perez and Mark Bagnall in 2014 and is headquartered in Cayman Islands. | Medical/Nursing Services | Chief Executive Officer | |
Seegpharm SA
 Seegpharm SA Pharmaceuticals: GenericHealth Technology Seegpharm SA is a Swiss pharmaceutical company that manufactures generic drugs. The private company was founded in 2012 and is based in Lugano, Switzerland. | Pharmaceuticals: Generic | Director/Board Member | |
| Royal Resources | Director/Board Member |
Statistik
International
| Vereinigte Staaten | 28 |
| Ägypten | 3 |
| Schweiz | 3 |
| Argentinien | 2 |
| Chile | 2 |
Sektoral
| Health Technology | 17 |
| Consumer Services | 10 |
| Finance | 3 |
| Commercial Services | 2 |
| Miscellaneous | 2 |
Operativ
| Director/Board Member | 16 |
| Corporate Officer/Principal | 8 |
| Director of Finance/CFO | 6 |
| Chief Executive Officer | 5 |
| President | 5 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| H. Perez | 11 |
| Dayton Misfeldt | 10 |
| Leo J. Redmond | 7 |
| Nathaniel A. Brown | 5 |
| Omar K. Haffar | 5 |
| Farid Ghazzaoui | 3 |
| Sherine Helmy | 2 |
